Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis
Our preliminary findings suggest that nICT followed by surgery offers comparable survival rates to nCRT, despite being less effective in pathologic outcomes. Nonetheless, nICT is a safe and feasible strategy for locally advanced ESCC, warranting further exploration to understand its impact on long-term survival.
Authors
- Yehan Zhou (ORCID: https://orcid.org/0000-0003-2486-6362)
- Ke Ma (ORCID: https://orcid.org/0000-0003-4942-9281)
- Huan Zhang
- Li Liu (ORCID: https://orcid.org/0000-0003-2314-8756)
- Xiang Zhuang (ORCID: https://orcid.org/0000-0002-0253-1476)
- Qifeng Wang (ORCID: https://orcid.org/0000-0001-8544-9007)
- Lei Wu (ORCID: https://orcid.org/0000-0001-9762-0684)
- Yi-Xiang Wang (ORCID: https://orcid.org/0000-0002-4021-4228)
- Lin Peng (ORCID: https://orcid.org/0000-0002-3418-7569)
Institutions
- University of Electronic Science and Technology of China (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1186/s12885-024-12946-8
- Citations
- 12
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.87
Funders
- Department of Science and Technology of Sichuan Province